7498 Results (Page 290 of 300)
Pharmaceuticals Markets Research Reports
Philippines Compression Therapy Market Analysis
Philippines Compression Therapy Market was valued at $8 Mn in 2022 and is estimated to reach $13 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Mölnlycke Health Care AB, Sigvaris, GC Medical Supply Co., Medi, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, and Hartmann Group.
China Exosome Research Market Analysis
The China Exosome Research Market was valued at $13.6 Mn in 2023 and is projected to grow at a CAGR of 17.5% from 2023 to 2023, to $42 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Clara Biotech, RoosterBio, Florica Therapeutics, BeiGene, Fosun Pharma, Sinopharm, Sinovac Biotech among others.
Japan Mouth Ulcer Therapeutics Market Analysis
The Japan Mouth Ulcer Therapeutics Market was valued at $94.5 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $127.7 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Otsuku Pharmaceuticals, Eisai, Daiichi Sankyo, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Saudi Arabia Compression Therapy Market Analysis
Saudi Arabia Compression Therapy Market was valued at $65 Mn in 2022 and is estimated to reach $112 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Medi France, Sigvaris, Juzo, Bauerfeind, Jobst, Lympha Press, FLA Orthopedics, Al-Johaifa Medical, Nahdi Pharmacy, and AstraZeneca.
Egypt Exosome Research Market Analysis
The Egypt Exosome Research Market was valued at $0.5 Mn in 2023 and is projected to grow at a CAGR of 17.5% from 2023 to 2023, to $1.5 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, Bio-Techne Crop, QIAGEN, Beckam Coulter, Lonza among others.
Malaysia Mouth Ulcer Therapeutics Market Analysis
The Malaysia Mouth Ulcer Therapeutics Market was valued at $2.4 Mn in 2023 and is projected to grow at a CAGR of 4.1% from 2023 to 2023, to $3.2 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Sanofi, CCM Pharmaceuticals, Duopharma Biotech Berhad, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer among others.
Singapore Compression Therapy Market Analysis
Singapore Compression Therapy Market was valued at $5 Mn in 2022 and is estimated to reach $7 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period. The growing prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry comprise firms such as Mölnlycke Health Care, Sigvaris, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, GC Medical Supply Co., Juzo, McKesson, and Cardinal Health.
France Exosome Research Market Analysis
The France Exosome Research Market was valued at $4.6 Mn in 2023 and is projected to grow at a CAGR of 15% from 2023 to 2023, to $12.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Ciloa, AGS Therapeutics, Lonza, Eli Lilly, Thermo Fisher Scientific, NanoSomix among others.
Singapore Mouth Ulcer Therapeutics Market Analysis
The Singapore Mouth Ulcer Therapeutics Market was valued at $1.8 Mn in 2023 and is projected to grow at a CAGR of 4.5% from 2023 to 2023, to $2.5 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bayer, Novartis, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer, Inc. among others.
South Africa Compression Therapy Market Analysis
South Africa Compression Therapy Market was valued at $25 Mn in 2022 and is estimated to reach $42 Mn in 2030, exhibiting a CAGR of 6.83% during the forecast period. The increasing incidence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Mölnlycke Health Care, Sigvaris Group, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, Medi-Globe Pharmaceuticals, Aspen Pharmacare, FBNQuest Healthcare, and Juzo.
Philippines Mouth Ulcer Therapeutics Market Analysis
The Philippines Mouth Ulcer Therapeutics Market was valued at $3.3 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $4.5 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bristol-Myers Squibb Company, Unilab, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Spain Compression Therapy Market Analysis
Spain Compression Therapy Market was valued at $73 Mn in 2022 and is estimated to reach $105 Mn in 2030, exhibiting a CAGR of 4.6% during the forecast period. The increase in the occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a crucial factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Medi, Sigvaris, Juzo, Jobst, Bauerfeind, Bauer Health GmbH, Orthopädische Industrie Herbst GmbH & Co. KG, DJO Global, FLA Orthopedics and Thuasne.
India Exosome Research Market Analysis
The India Exosome Research Market was valued at $3.1 Mn in 2023 and is projected to grow at a CAGR of 19% from 2023 to 2023, to $10.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as ExoDx, Reelabs, Thermo Fisher Scientific, MagGenome, Clevergene Biocorp, Theranosis Life Sciences among others.
Vietnam Mouth Ulcer Therapeutics Market Analysis
The Vietnam Mouth Ulcer Therapeutics Market was valued at $7.6 Mn in 2023 and is projected to grow at a CAGR of 4.13% from 2023 to 2023, to $10.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Hau Giang Pharmaceuticals, Traphaco, Bristol-Myers Squibb Company, Bayer, Novartis, GlaxoSmithKline PLC, Pfizer, Inc. among others.
UAE Compression Therapy Market Analysis
UAE Compression Therapy Market was valued at $19 Mn in 2022 and is estimated to reach $32 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Medi France, Sigvaris, Juzo, Bauerfeind, Jobst, Lympha Press, FLA Orthopedics, Al-Johaifa Medical, Nahdi Pharmacy, and AstraZeneca.
Indonesia Exosome Research Market Analysis
The Indonesia Exosome Research Market was valued at $1.0 Mn in 2023 and is projected to grow at a CAGR of 16% from 2023 to 2023, to $2.9 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Stem Cell and Cancer Institute, Prodia Group, Kalbe Farma, PT Bio Farma, Dexa Medica among others.
Egypt Mouth Ulcer Therapeutics Market Analysis
The Egypt Mouth Ulcer Therapeutics Market was valued at $4.3 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $6.2 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as EIPICO, Pharco Pharmaceuticals, Amoun Pharmaceuticals, GlaxoSmithKline PLC, among others.
UK Compression Therapy Market Analysis
UK Compression Therapy Market was valued at $99 Mn in 2022 and is estimated to reach $131 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry encompass entities such as Sigvaris, Medi, Juzo, Jobst, Bauerfeind, LymphoCare, Activa Healthcare, Amoena, Ofa Bamberg, and Variteks.
Japan Exosome Research Market Analysis
The Japan Exosome Research Market was valued at $10.5 Mn in 2023 and is projected to grow at a CAGR of 16.5% from 2023 to 2023, to $30.6 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as CRAIF, Toyobo, Kangstem Biotech, Digzyme, Thermo Fisher Scientific among others.
Kenya Mouth Ulcer Therapeutics Market Analysis
The Kenya Mouth Ulcer Therapeutics Market was valued at $1.1 Mn in 2023 and is projected to grow at a CAGR of 5.0% from 2023 to 2023, to $1.5 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Dawa Life Sciences, Bayer, Beta Healthcare International, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer among others.
US Compression Therapy Market Analysis
US Compression Therapy Market was valued at $1596 Mn in 2022 and is estimated to reach $2118 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, serves as a significant growth driver for the compression therapy market. Key players in this industry comprise Bauerfeind, Jobst, Medi, Sigvaris, Juzo, LympheDiv, Gibaud, Varisport, CEP, and McDavid.
Kenya Exosome Research Market Analysis
The Kenya Exosome Research Market was valued at $0.1 Mn in 2023 and is projected to grow at a CAGR of 17.1% from 2023 to 2023, to $0.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, Agilent Technologies, Inc., QIAGEN, FUJIFILM Irvine Scientific, Cusabio Technology Llc, Nexosome-Oncology, Norgen Biotek Corp., Miltenyi Biotec, Beckman Coulter, Inc., and Hitachi, Ltd., among others.
South Africa Mouth Ulcer Therapeutics Market Analysis
The South Africa Mouth Ulcer Therapeutics Market was valued at $9.9 Mn in 2023 and is projected to grow at a CAGR of 5.13% from 2023 to 2023, to $14 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Aspen Pharmacare, Cipla Medpro, Sanofi, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Vietnam Compression Therapy Market Analysis
Vietnam Compression Therapy Market was valued at $19 Mn in 2022 and is estimated to reach $30 Mn in 2030, exhibiting a CAGR of 5.83% during the forecast period. The growing prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry comprise firms such as Mölnlycke Health Care, Sigvaris, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, GC Medical Supply Co., Juzo, McKesson, and Cardinal Health.
India Mouth Ulcer Therapeutics Market Analysis
The India Mouth Ulcer Therapeutics Market was valued at $27.6 Mn in 2023 and is projected to grow at a CAGR of 6.9% from 2023 to 2023, to $44.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Cipla, Mylan, Dr Reddy’s, Hetero among others.
